Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA
Moat Ross exercised options for 5,808 Kiniksa Pharmaceuticals International, Plc shares (Form 4)
Traded Jan 15 to Apr 1, 2026 · Filed Apr 3, 2026
From Jan 15 to Apr 1, 2026, Moat Ross (CHIEF OPERATING OFFICER) exercised options for 5,808 Kiniksa Pharmaceuticals International, Plc shares, leaving 14,396 shares. Filed Apr 3, 2026 (Form 4).
- Options exercised
- 5,808 shares
- Holding after
- 14,396 shares
- Trading plan
- No
- Role
- CHIEF OPERATING OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jan 15, 2026 | Class A Ordinary Share | Award | 879 | US$24.16 | 10,294 | Direct |
| Apr 1, 2026 | Class A Ordinary Share | Option exercise | 5,808 | 16,102 | Direct | |
| Apr 1, 2026 | Class A Ordinary Share | Shares withheld for tax | 1,706 | US$48.13 | 14,396 | Direct |
Source
Related
- Kiniksa Pharmaceuticals International, Plc
- Moat Ross
- Kiniksa Pharmaceuticals International, Plc shareholders
- Form 4 · Moat Ross · Sep 3, 2026
- Form 4 · Moat Ross · Apr 13, 2026
- Form 4 · Moat Ross · Apr 8, 2026
- Form 4 · Megna Michael R · Sep 3, 2026
- Form 4 · Paolini John F. · Sep 3, 2026
- Form 4 · Patel Sanj K · Sep 3, 2026
- Form 4 · Ragosa Mark · Sep 3, 2026
- Form 4 · Quart Barry D · Aug 21, 2026